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BaCKGRoUND
Probiotics are living microorganisms providing health beneficial effect to the host (1). Probiotics 
have been used for the treatment or prevention of various diseases related to diarrhea (2), cho-
lesterol (3) immune function (4), and inflammatory bowel disease (5). In addition, recent study 
also presents that probiotic bacteria in the Bifidobacterium and Lactobacillus genera are able to 
have therapeutic effects in the patients of psychological disorders, such as depression, anxiety, and 
memory (6).
Lactobacillus casei is a Gram-positive bacterium that naturally inhabits the human and animal 
gastrointestinal and mouth organs (7). As its name implies, this heterofermentative microorganism 
is the dominant species present in ripening cheddar cheese (8). In probiotic aspects, L. casei showed 
beneficial roles in the activation of the gut mucosal immune system (9), treatment of diabetics (10), 
and chronic constipation (11). In the previous study, we isolated L. casei LC5 strain from fermented 
dairy products, which showed immune regulatory functions, especially, therapeutic effect on atopic 
dermatitis as a member of complex probiotics (12–14).
In order to gain better insight of the probiotic effect on atopic dermatitis, we analyzed the genome 
sequence of L. casei LC5. According to the report of NCBI Genome,1 more than two hundreds 
of Lactobacillus organisms are sequenced and their beneficial properties derived from genomic 
information are used in the food industry. However, the available genomes of L. casei strains as 
members of health promoting probiotics are still insufficient. Furthermore, L. casei strains are 
frequently confused with the closely related strains such as Lactobacillus paracasei and Lactobacillus 
rhamnosus. Therefore, comparative study in a whole genome scale is required to clarify taxonomic 
association of L. casei LC5 as well as its functional characteristics. The availability of the genomic 
information of L. casei LC5 will aid as a basis for further in-depth analysis of the probiotic function 
of L. casei strains.
MateRIaLS aND MetHoDS
Bacterial Strains and DNa preparation
Lactobacillus casei LC5 was isolated from fermented dairy products and commercially used as 
probiotics in Korea (15). L. casei LC5 was cultured aerobically in MRS medium (Difco, USA) at 
37°C for 18 h. Genomic DNA from L. casei LC5 was extracted and purified using a QIAamp DNA 
1 https://www.ncbi.nlm.nih.gov/genome/?term=Lactobacillus.
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Mini Kit (Qiagen, Germany). The concentration of genomic DNA 
was qualified with NanoDrop 2000 UV–vis spectrophotom-
eter (Thermo Scientific, USA) and Qubit 2.0 fluorometer (Life 
Technology, USA).
Genome Sequencing, assembly,  
and annotation
Whole genome sequencing of L. casei LC5 was carried out 
by using PacBio RS II platform. A 20  kb DNA library was 
constructed according to the manufacturer’s instruction and 
sequenced using single molecule real-time (SMRT) sequencing 
technology with the P6 DNA polymerase and C4 chemistry. A 
total of 138,180 subreads (1.04 Gb) were obtained with 400-fold 
coverage. The average length of subreads was 7,550 bp and N50 
was 10,940 bp. Genome assembly was performed using HGAP 
3.0 (16) with default options. The annotation was carried out with 
NCBI Prokaryotic Genome Annotation Pipeline (17) through 
NCBI Genome submission portal (GenomeSubmit at http://
ncbi.nlm.nih.gov). The chromosome topology was drawn using 
DNAPlotter (18). Clusters of orthologous groups (COG) catego-
ries were assigned to the coding genes using BLASTP (e-value: 
1e−3) against COG database (19).
phylogenetic analysis and Comparative 
Genomic analysis
For phylogenetic and comparative study, we downloaded 19 
genome sequences of L. casei group (10 of L. casei, 8 of L. para-
casei, 1 of Lactobacillus zeae, and 1 of L. rhamnosus) from NCBI 
genome database.2 A list of the reference genomes are as fol-
lows: L. casei Zhang (NC_014334), L. casei BL23 (NC_010999), 
L. casei BD-II (NC_017474), L. casei LC2W (NC_017473), 
 L. casei 12A (NZ_CP006690), L. casei W56 (NC_018641), L. casei 
LcY (NZ_CM001848), L. casei LcA (NZ_CM001861), L. casei 
LOCK919 (NC_021721), L. casei ATCC 393 (NZ_AP012544), 
L. paracasei ATCC 334 (NC_008526), L. paracasei 362.5013889 
(NC_022112), L. paracasei N1115 (NZ_CP007122), L. paracasei 
JCM (NZ_AP012541), L. paracasei CAUH35 (NZ_CP012187), 
L. paracasei L9 (NZ_CP012148), L. paracasei KL1 (NZ_
CP013921), L. zeae DSM 20178 (NZ_AZCT01000001), and 
L. rhamnosus GG (NC_013198). The assembly levels of all 
genomes are “complete genome” or chromosome except L. zeae 
DSM 20178 (includes 55 scaffolds). Because we failed to fetch 
full-length 16S rRNA gene from the genome of L. zeae DSM 
20178, we alternatively used a 16S rRNA gene of L. zeae RIA 482 
(NR_037122), the closest sequence of DSM 20178 (sequence 
identity = 99.9%), in the phylogenetic analysis.
The evolutionary history was inferred by using the maximum 
likelihood method based on the Tamura–Nei model (20). All 
positions containing gaps and missing data were eliminated. 
There were a total of 1521 positions in the final dataset. Those 
phylogenetic analyses were conducted in MEGA6 (21). To 
compute genomic distance, we first computed orthologous 
average nucleotide identity (OrthoANI) values using ortholo-
gous average nucleotide identity tool (22). The OrthoANI 
2 http://www.ncbi.nlm.nih.gov/genome/.
values were converted to distance values by following formula: 
distance = 1 − (OrthoANI/100). The evolutionary distance was 
computed using the neighbor-joining method of MEGA6 (21). 
The tree is drawn to scale with branch lengths in the same units 
as those of the evolutionary distances used to infer the phyloge-
netic tree. The resulting phylogenetic tree was produced using 
MEGA6. Pan-genomic study using Panseq (23) was performed 
to investigate the genomic conservation and finding novel region 
in the sequenced genome.
ReSULtS
Genome Characteristics of L. casei LC5
We obtained a complete genome sequence of L. casei LC5 using 
SMRT sequencing. This genome has a chromosome and no orga-
nelle sequences. The total size of the genome is 3,132,867 bp and 
its GC content is 47.9%. A total of 2,925 genes were detected from 
the genome sequence. The number of coding CDS is 2,817 and 
pseudogenes is 31. Seventy seven RNAs (15 rRNAs, 59 tRNAs, 
and 3 non-coding RNAs) were also identified. Repeating region 
or CRISPR array was not identified. Genomic features of L. casei 
LC5 are shown in Figure 1A.
Although L. casei LC5 was identified as a strain of L. casei, 
it showed different genomic features compared to the other 
published L. casei strains; According to the summary of 37 
L. casei genomes deposited in NCBI Assembly, the median 
length is 3.01993  Mb, the median of coding genes is 2,712, 
and the median of GC contents is 46.4%. An interesting point 
is that those genomes can be split into two groups by the 
difference of GC contents, high-GC group (47.7–47.9%) and 
low-GC group (46.2–46.6%). Five genomes (ATCC 393, N87, 
867_LCAS, Lbs2, JCM 1134) and L. casei LC5 belong to the 
high-GC group and the other genomes belong to the low-GC 
group (Table 1).
Comparative Study of L. casei Group
Comparative study of both 16S rRNA genes and whole 
genome sequences revealed that the closest genome of L. 
casei LC5 was L. casei ATCC 393 and second closest one 
was L. zeae DSM 20178. The three genomes which showed 
distinguishable differences on the comparative study, LC5, 
ATCC 393, and L. zeae DSM 20178, belong to the high-GC 
group as described in the above section. In contrast to the 
phylogenetic distances based on 16S rRNA gene among the 
high-GC group (below 0.001), the distances between the 
high-GC group and the low-GC group were above 0.003 
(Figure 1C). It was also supported by the estimation result of 
the whole genomic comparison. Average nucleotide identity 
(ANI) values among the high-GC group were above 94% 
whereas ANI values between two groups were below 80% 
(Figure 1D). All the L. casei strains and L. paracasei strains 
belonging to the low-GC group showed the high genomic 
similarity of 98% or higher.
Functional Classification
Functional classification based on COG assigned the 2,334 CDSs 
into the 1,309 COG numbers. From the comparison of functional 
FIGURe 1 | Genome characteristics of Lactobacillus casei LC5 genome. (a) Circular map of genomic features; eight tracks were plotted in the map. Track 
1 (light blue; outermost), forward-stranded coding CDS; Track 2 (blue), reverse-stranded coding CDS; Track 3 (light purple), rRNA including 5S, 16S, and 23S; 
Track 4 (green), Trna; Track 5 (orange), peak of pan-genomic conservation; Track 6 (red), novel regions (below 85% similarities with the other genomes); Track 7 
(light green and purple), GC content; and Track 8 (light green and purple), GC skew. (B) Abundance of clusters of orthologous groups (COG) categories; black 
point indicates the abundance of LC5 for each category. A box and whisker plot indicates a statistical distribution of the COG categories of 19 L. casei genomes. 
(C) Phylogenetic tree of L. casei group based on 16S rRNA genes and (D) phylogenetic tree of L. casei group based on average nucleotide identity. The value 
0.02 of the ruler in (D) indicates 2% of genomic dissimilarity. Red boxes on the (C,D) indicate the genomes associated to the high-GC group and green boxes 
indicate the genomes associated to the low-GC group.
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categories against the 19 L. casei group genomes, we found that 
L. casei LC5 contains the high number of proteins which associ-
ate with “carbohydrate transport and metabolism (G)” (376 
proteins) and “transcription (K)” (239 proteins) excluding two 
unknown categories, “general function prediction only (R)” and 
“function unknown (S)” as shown in Figure 1B. L. casei LC5 has 
at least 36 more proteins than the other genomes on the category 
G and has at least 8 more proteins than the other genomes on 
the category K. The gene expansion of those two functional 
categories in the LC5 genome is not found on the other members 
of high-GC group. Although the genomes belonging to high-GC 
group showed high similarities to each other and the genomes 
belonging to the high-GC group do not have excessive proteins 
on the categories, G and K, when compared to those belonging 
to the low-GC group. Moreover, L. casei ATCC 393 which is the 
most similar genome of LC5 has fewer proteins than the average 
number of those categories, 223 proteins for the category G and 
192 proteins for the category K.
In the previous study, probiotic LC5 strain isolated from 
Korean fermented dairy product showed great therapeutic effect 
on atopic dermatitis. Here, we report a genomic overview and 
distinguishing gene features of LC5 by comparative genomic 
analysis of 20 related strains. The genomic data presented in this 
report will broaden our knowledge about roles and mechanisms 
taBLe 1 | Genome summary of Lactobacillus casei group.
organism/name Strain Clade assembly level Size (Mb) GC% GC group
L. casei LC5 LC5 L. casei Complete genome 3.13 47.9 High
L. casei str. Zhang Zhang L. casei Complete genome 2.90 46.4 Low
L. casei BL23 BL23 L. casei Complete genome 3.08 46.3 Low
L. casei BD-II BD-II L. casei complete genome 3.13 46.3 Low
L. casei LC2W LC2W L. casei Complete genome 3.08 46.4 Low
L. casei 12A 12A L. casei Complete genome 2.91 46.4 Low
L. casei W56 W56 L. casei Complete genome 3.13 46.3 Low
L. casei LOCK919 LOCK919 L. casei Complete genome 3.14 46.2 Low
L. casei subsp. casei ATCC 393 ATCC 393 L. casei Complete genome 2.95 47.9 High
L. casei LcY LcY L. casei Chromosome 3.10 46.3 Low
L. casei LcA LcA L. casei Chromosome 3.13 46.3 Low
L. casei A2-362 A2-362 L. casei Scaffold 3.19 46.2 Low
L. casei KL1-Liu L. casei Scaffold 2.85 46.6 Low
L. casei DSM 20011 = JCM 1134 DSM 20011 L. casei Scaffold 2.82 46.5 Low
L. casei 21/1 21/1 L. casei Contig 3.22 46.2 Low
L. casei 32G 32G L. casei Contig 3.01 46.4 Low
L. casei A2-362 A2-362 L. casei Contig 3.36 46.1 Low
L. casei CRF28 CRF28 L. casei Contig 3.04 46.3 Low
L. casei M36 M36 L. casei Contig 3.15 46.3 Low
L. casei T71499 T71499 L. casei Contig 3.00 46.2 Low
L. casei UCD174 UCD174 L. casei Contig 3.07 46.4 Low
L. casei UW1 UW1 L. casei Contig 2.87 46.4 Low
L. casei UW4 UW4 L. casei Contig 2.76 46.4 Low
L. casei Lc-10 Lc-10 L. casei Contig 2.95 46.4 Low
L. casei Lpc-37 Lpc-37 L. casei Contig 3.08 46.3 Low
L. casei UW4 UW4 L. casei Contig 2.63 46.4 Low
L. casei 12A 12A L. casei Contig 2.93 46.3 Low
L. casei 5b 5b L. casei Contig 3.02 46.3 Low
L. casei N87 L. casei Contig 3.00 47.9 High
L. casei 867_LCAS L. casei Contig 3.09 47.9 High
L. casei DPC6800 L. casei Contig 3.05 46.4 Low
L. casei Lc1542 L. casei Contig 2.92 46.5 Low
L. casei 1316.rep1_LPAR L. casei Scaffold 2.86 46.5 Low
L. casei 1316.rep2_LPAR L. casei Scaffold 2.79 46.4 Low
L. casei 844_LCAS L. casei Scaffold 2.79 46.4 Low
L. casei BM-LC14617 L. casei Scaffold 3.04 46.3 Low
L. casei Lbs2 L. casei Scaffold 3.27 47.9 High
L. casei DSM 20011 = JCM 1134 JCM 1134 L. casei Contig 2.78 47.7 High
Lactobacillus paracasei ATCC 334 ATCC 334 L. paracasei Complete genome 2.92 46.6 Low
L. paracasei subsp. paracasei 8700:2 8700:2 L. paracasei Complete genome 3.03 46.3 Low
L. paracasei N1115 N1115 L. paracasei Complete genome 3.06 46.5 Low
L. paracasei subsp. paracasei JCM 8130 JCM 8130 L. paracasei Complete genome 3.02 46.6 Low
L. paracasei CAUH35 L. paracasei Complete genome 2.97 46.3 Low
L. paracasei L9 L. paracasei Complete genome 3.08 46.3 Low
L. paracasei KL1 L. paracasei Complete genome 2.92 46.6 Low
Lactobacillus zeae DSM 20178 = KCTC 3804 DSM 20178 L. zeae Scaffold 3.12 47.7 High
Lactobacillus rhamnosus GG GG (ATCC 53103) L. rhamnosus Complete genome 3.01 46.7 Low
4
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of microorganisms ameliorating symptoms of immune diseases 
and help developing functional probiotics for the treatment of 
immune disorders.
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